BR0212341A - Processo para a preparação de hexaidro-furo[2,3-b]furan-3-ol - Google Patents

Processo para a preparação de hexaidro-furo[2,3-b]furan-3-ol

Info

Publication number
BR0212341A
BR0212341A BR0212341-0A BR0212341A BR0212341A BR 0212341 A BR0212341 A BR 0212341A BR 0212341 A BR0212341 A BR 0212341A BR 0212341 A BR0212341 A BR 0212341A
Authority
BR
Brazil
Prior art keywords
furan
furo
hexahydro
preparation
preparing
Prior art date
Application number
BR0212341-0A
Other languages
English (en)
Other versions
BRPI0212341B8 (pt
BRPI0212341B1 (pt
Inventor
Bart Rudolf Romanie Kesteleyn
Daminique Louis Nest Surleraux
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0212341(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BR0212341A publication Critical patent/BR0212341A/pt
Publication of BRPI0212341B1 publication Critical patent/BRPI0212341B1/pt
Publication of BRPI0212341B8 publication Critical patent/BRPI0212341B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

"PROCESSO PARA A PREPARAçãO DE HEXAIDRO-FURO[2,3-B]FURAN-3-OL". A presente invenção refere-se a um método para preparação de hexaidro-furo[2,3-b]furan-3-ol, bem como novos intermediários para uso no método. Mais especificamente, a invenção refere-se a um método estereos-seletivo para a preparação de hexaidro-furo[2,3-b]furan-3-ol e a um método receptível em escala industrial.
BRPI0212341A 2001-09-10 2002-09-06 compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos BRPI0212341B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01203416.1 2001-09-10
EP01203416 2001-09-10
PCT/EP2002/010062 WO2003022853A1 (en) 2001-09-10 2002-09-06 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Publications (3)

Publication Number Publication Date
BR0212341A true BR0212341A (pt) 2004-07-27
BRPI0212341B1 BRPI0212341B1 (pt) 2019-04-02
BRPI0212341B8 BRPI0212341B8 (pt) 2021-05-25

Family

ID=8180908

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0212341A BRPI0212341B8 (pt) 2001-09-10 2002-09-06 compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos

Country Status (28)

Country Link
US (1) US7126015B2 (pt)
EP (1) EP1448567B1 (pt)
JP (1) JP4521185B2 (pt)
KR (1) KR100894673B1 (pt)
CN (2) CN100519561C (pt)
AP (1) AP1758A (pt)
AR (1) AR036501A1 (pt)
AT (1) ATE453648T1 (pt)
AU (1) AU2002333809C1 (pt)
BR (1) BRPI0212341B8 (pt)
CA (1) CA2459168C (pt)
CY (1) CY1109974T1 (pt)
DE (1) DE60234952D1 (pt)
DK (1) DK1448567T3 (pt)
EA (1) EA010883B1 (pt)
ES (1) ES2338538T3 (pt)
HK (1) HK1068887A1 (pt)
HR (1) HRP20040320B1 (pt)
HU (1) HU229505B1 (pt)
IL (2) IL160166A0 (pt)
MX (1) MXPA04002247A (pt)
NO (1) NO328934B1 (pt)
NZ (1) NZ531641A (pt)
PL (1) PL224030B1 (pt)
PT (1) PT1448567E (pt)
SI (1) SI21463B (pt)
WO (1) WO2003022853A1 (pt)
ZA (1) ZA200401501B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1532127E (pt) * 2002-06-27 2007-01-31 Smithkline Beecham Corp Preparação de estereoisómeros de ( 3alfa, 3alfa/beta, 6alfa/beta )hexa-hidrofuro ( 2,3-b ) furan-3-ol
AU2003275675A1 (en) * 2002-12-27 2004-07-29 Sumitomo Chemical Company, Limited Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
ME01059B (me) 2003-12-23 2012-10-20 Janssen Sciences Ireland Uc Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata
TWI383975B (zh) * 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
JP5549898B2 (ja) * 2006-03-31 2014-07-16 独立行政法人産業技術総合研究所 ５−ヒドロキシメチル−２−フルフラールの製造法
CN101541775B (zh) * 2006-11-09 2011-12-28 泰博特克药品有限公司 六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
CN101024646B (zh) * 2007-02-06 2010-07-14 启东东岳药业有限公司 4-甲氧基呋喃并呋喃-2-酮的纯化方法
BRPI0810609A2 (pt) 2007-04-27 2014-10-21 Tibotec Pharm Ltd Métodos para a preparação de derivados de n-isobutil-n-(2-hidróxi-a-amino-4-fenilbutil)-p-nitrobe nzenossulfonilamida
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
US20110257111A1 (en) * 2008-10-24 2011-10-20 Harbeson Scott L Hydroxyethlamino Sulfonamide Derivatives
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
BR112012009956A2 (pt) 2009-10-30 2015-09-29 Lupin Ltd um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
PL2528923T3 (pl) 2010-01-28 2015-01-30 Mapi Pharma Ltd Sposób wytwarzania darunawiru i pochodnych darunawiru
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
US8802724B2 (en) 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
ES2848216T3 (es) 2012-07-24 2021-08-05 Laurus Labs Ltd Un proceso para la preparación de Darunavir
JPWO2014024898A1 (ja) * 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103864813B (zh) * 2012-12-18 2017-02-22 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
US10633390B2 (en) * 2015-06-25 2020-04-28 Msn Laboratories Private Limited Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
WO2017041228A1 (zh) * 2015-09-08 2017-03-16 浙江九洲药业股份有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN110423228B (zh) * 2016-02-05 2023-01-10 成都博腾药业有限公司 一种制备地瑞那韦中间体的方法
EP3532478B1 (en) 2016-10-27 2021-05-26 Gilead Sciences, Inc. Crystalline form of darunavir free base
CN106928248B (zh) * 2017-02-04 2019-01-04 青岛科技大学 一种制备(3R,3aS,6aR)六氢呋喃并[2,3-b]呋喃-3-醇的方法
CN110272398B (zh) 2018-03-16 2022-11-29 江苏瑞科医药科技有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN114853774A (zh) * 2022-06-24 2022-08-05 盐城迪赛诺制药有限公司 一种达卢那韦关键中间体的制备方法
CN115557964A (zh) * 2022-10-18 2023-01-03 启东东岳药业有限公司 一种药物化合物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4325970A (en) * 1980-10-09 1982-04-20 Hoffmann-La Roche Inc. 15-Acetyl-prostaglandins
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
AU6828894A (en) * 1993-05-14 1994-12-12 Merck & Co., Inc. Hiv protease inhibitors
DE69415326T2 (de) 1993-08-24 1999-06-02 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
RU2089545C1 (ru) * 1994-09-28 1997-09-10 Ярославский государственный технический университет Способ получения 2-метил-2-этил-1,3-диоксолан-4-ил-метилметакрилата
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
RU2211047C2 (ru) * 1997-01-30 2003-08-27 Новартис Аг Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
CA2872424C (en) 1998-06-23 2017-03-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
HU228938B1 (hu) * 1999-10-06 2013-06-28 Us Government Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2- -(hidroxi-propil)}-karbamát mint retrovírus proteáz gátló

Also Published As

Publication number Publication date
EA200400430A1 (ru) 2004-08-26
HK1068887A1 (en) 2005-05-06
ATE453648T1 (de) 2010-01-15
JP2005502707A (ja) 2005-01-27
CN1553915A (zh) 2004-12-08
AU2002333809B8 (en) 2008-07-03
HRP20040320B1 (hr) 2012-11-30
BRPI0212341B8 (pt) 2021-05-25
WO2003022853A1 (en) 2003-03-20
ES2338538T3 (es) 2010-05-10
CN101172980A (zh) 2008-05-07
MXPA04002247A (es) 2005-09-07
CA2459168C (en) 2014-01-28
SI21463B (sl) 2011-08-31
HUP0402140A2 (hu) 2005-02-28
US7126015B2 (en) 2006-10-24
EA010883B1 (ru) 2008-12-30
HU229505B1 (hu) 2014-01-28
CN101172980B (zh) 2011-11-16
PL367817A1 (en) 2005-03-07
JP4521185B2 (ja) 2010-08-11
DK1448567T3 (da) 2010-04-26
SI21463A (sl) 2004-10-31
NZ531641A (en) 2005-08-26
BRPI0212341B1 (pt) 2019-04-02
HUP0402140A3 (en) 2007-05-29
IL160166A0 (en) 2004-07-25
EP1448567A1 (en) 2004-08-25
NO328934B1 (no) 2010-06-21
KR100894673B1 (ko) 2009-04-24
AU2002333809B2 (en) 2008-02-28
ZA200401501B (en) 2005-07-27
AU2002333809B9 (en) 2008-06-26
NO20041434L (no) 2004-06-10
AU2002333809C1 (en) 2009-02-05
AP2004002981A0 (en) 2004-03-31
IL160166A (en) 2012-05-31
EP1448567B1 (en) 2009-12-30
HRP20040320A2 (en) 2005-04-30
KR20040029425A (ko) 2004-04-06
AP1758A (en) 2007-07-30
PL224030B1 (pl) 2016-11-30
DE60234952D1 (de) 2010-02-11
PT1448567E (pt) 2010-03-12
CY1109974T1 (el) 2014-09-10
CN100519561C (zh) 2009-07-29
AR036501A1 (es) 2004-09-15
US20040249175A1 (en) 2004-12-09
CA2459168A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
BR0212341A (pt) Processo para a preparação de hexaidro-furo[2,3-b]furan-3-ol
BRPI0718706B8 (pt) métodos para a preparação de hexa-hidrofuro[2,3- b]furan-3-ol
BR0107425A (pt) Processo para a preparação compostos de derivados de ácido 3-hidróxi picolìnico e uso dos compostos
SV2005001918A (es) Metodos para preparar derivados 7-(b-d-ribofuranosilo sustituido en 2')-4 (nr2r3)-5(etin-1-ilo sustituido)-pirrol[2,3-d]pirimidina
BR0017030A (pt) Derivados de tiazolilamida
PT1210384E (pt) Composicoes de revestimento inorganicas, um processo para a sua preparacao bem como a sua utilizacao
AU2003287038A1 (en) METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO (2, 3-b) FURAN AND RELATED COMPOUNDS
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0115963A (pt) Derivados de benzofurano e benzotiofeno
ECSP034754A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad
BRPI0416426A (pt) dendrìmeros e seu processo de preparação, compostos, processo para a preparação de compostos e uso dos dendrìmeros
AR032369A1 (es) Procedimiento para preparar 3-amino-2-cloro-4-metilpiridina
EA200301292A1 (ru) Способ синтеза тропенола для его получения в промышленном масштабе
BR9908964A (pt) Processo para produção de derivados de purina e intermediários para os mesmos
ITFI990169A0 (it) Analoghi di ceramidi, processo per la loro preparazione e loro uso come antitumorali.
BR9909151A (pt) processos para preparação de intermediários
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
BR0311761A (pt) Processo para a preparação de 4,6-dicloro-5-fluorpirimidina
BRPI0418023A (pt) triazolopirimidina com propriedades fungicidas
BRPI0411248A (pt) método para produzir um polipeptìdeo
PT1444244E (pt) Processo para a preparacao de desclaritromicina, assim como produtos intermedios
BRPI0409644A (pt) processo para a preparação de nicotinaldeìdos
BRPI0113727B8 (pt) Processo para a produção de halo-4-fenoxiquinolinas.
EA200501535A1 (ru) Способ получения имидазопиридин-8-онов

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: TIBOTEC PHARMACEUTICALS LTD. (IE)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070001806/RJ DE 05/01/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TIBOTEC PHARMACEUTICALS (IE)

B25D Requested change of name of applicant approved

Owner name: JANSSEN R AND D IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/09/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 06/09/2022